(SRXH) SRx Health Solutions Inc. Company Overview

What does SRX Global do?

SRX Global Inc. is a NYSE American-listed holding and capital-allocation platform trading under ticker SRXH. The legal name changed from SRx Health Solutions Inc. after the June 18, 2026 acquisition of EMJ Crypto Technologies and related intellectual property. That change is more than cosmetic: the former Canadian specialty-pharmacy operations were wound down and classified as discontinued, while the current company combines the Halo premium pet-products business with an AI-enabled investment and asset-management strategy. The company describes its purpose as building value through capital, intelligence, and execution on its official investor-relations site.

Which activities define the company today?

How does SRX Global make money?

The business model now has three distinct return engines. Halo sells physical products through online retailers, international distributors, and selected brick-and-mortar accounts. EMJX is intended to generate investment returns, improve treasury allocation, and potentially commercialize its market-regime signal for digital-asset treasuries, miners, and funds. The holding company can also earn realized gains, dividends, interest, or strategic value from minority investments and special situations. These streams have different accounting patterns, risk profiles, and valuation methods.

What are the revenue and return streams?

Which channels and assets matter most?

Halo is a digitally concentrated consumer business

For the quarter ended March 31, 2026, Halo generated $2.872 million of digital sales, $339,000 of international sales, and $228,000 of brick-and-mortar sales. Digital therefore represented 84% of quarterly net sales. The March 2026 Form 10-Q also states that two digital wholesale customers accounted for $2.8 million of quarterly sales, making channel concentration a core operating issue.

Where is customer demand located?

What does the latest reported period show?

The latest filed GAAP quarter is the three months ended March 31, 2026, before the EMJX acquisition closed. It therefore measures Halo plus treasury positions and financing effects, not the final SRX Global platform. Net sales were $3.439 million, gross profit was $1.275 million, and gross margin was approximately 37.1%. Selling, general and administrative expense of $3.093 million exceeded gross profit, producing a $1.818 million operating loss. Other expense of $4.561 million—driven largely by interest and fair-value declines—expanded the net loss to $6.381 million.

How should the June 2026 update be interpreted?

Management’s July 8 update is fresher but preliminary and unaudited. It reported approximately $40 million of cash, more than $15 million of short-term investments, no debt, estimated NAV of approximately $60 million, and 19,517,834 post-consolidation common shares as of June 30 or July 6, depending on the metric. The preliminary balance-sheet update should not be substituted for the June-quarter Form 10-Q, expected by August 14, 2026, because final classifications and transaction accounting may differ.

How did SRX Global’s strategic history reshape the company?

The current company is the product of several rapid pivots rather than a long, stable operating history. That matters because historical financial statements span different businesses, accounting acquirers, discontinued operations, and capital structures.

1. Pre-2025
   Better Choice operated Halo as a pet-health and wellness company, while the Canadian SRx business assembled specialty-pharmacy and healthcare assets.
2. April 2025
   The merger closed. SRx Canada became the accounting acquirer, but Halo ultimately became the surviving continuing operation after the healthcare business deteriorated.
3. August 2025
   Canadian specialty-pharmacy operations entered CCAA proceedings, leading to wind-down and discontinued-operation treatment.
4. December 2025
   The company agreed to acquire EMJX and related intellectual property for an equity-based transaction valued at approximately $55 million.
5. June 18, 2026
   The EMJX acquisition closed, SRX acquired 100% of EMJC, CCC Crypto and the relevant IP, and the legal name changed to SRX Global Inc. The closing Form 8-K records the share consideration.
6. July 6, 2026
   A 1-for-60 share consolidation simplified the quoted share count and addressed low-price listing concerns.
7. July 15, 2026
   NYSE American notified the company that it had regained compliance with continued-listing standards, removing an immediate listing overhang.

What is the lasting implication of these turning points?

Comparability is the largest analytical constraint. FY2025 revenue reflects only the post-merger continuing Halo business, prior healthcare results sit in discontinued operations, Q2 FY2026 predates the EMJX closing, and the June 2026 NAV update is preliminary. A serious model therefore needs a transaction bridge rather than a simple historical growth rate.

Who are SRX Global’s competitors?

SRX Global competes in two separate arenas. Halo faces global packaged-pet-food companies, specialist natural brands, retailer private labels, and digitally native entrants. The FY2025 Form 10-K names Mars, Nestlé, J.M. Smucker, Blue Buffalo, Wellness, Fromm, Orijen, Merrick, Stella & Chewy, Open Farm, and Freshpet. EMJX and the capital-allocation platform compete more broadly with digital-asset treasury companies, multi-strategy investment firms, activist investors, special-situations funds, and public holding companies.

What determines market position?

For Halo, market position depends on repeat purchase, retailer ranking, gross margin, product quality, advertising efficiency, and supply reliability. For EMJX, credibility will depend on realized, risk-adjusted returns, transparent reporting, drawdown control, and whether institutional users pay for the signal. The company reported a 24.8% paper-traded EMJX return from February 11 through July 10, 2026 versus a 4.2% decline in Bitcoin, but explicitly stated that no actual capital was deployed. That distinction is critical: paper execution does not capture the full effects of slippage, liquidity, financing, and market impact.

What gives SRX Global a competitive advantage—and what remains unproven?

Potential resource advantages

The strongest plausible advantage is organizational flexibility. Management can choose control investments, minority positions, special situations, fixed-income reserves, digital assets, or reinvestment in Halo. The July 2026 shareholder letter frames AI as infrastructure for sourcing, diligence, underwriting, portfolio monitoring, pricing, supply chain, and customer acquisition.

Why the moat is not yet established

A resource is not a durable moat until it creates superior economics that competitors cannot easily copy. Halo’s brand has recognition but lacks scale. EMJX’s intellectual property may be differentiated, yet the public evidence is still a short paper-traded period. The investment portfolio is broad, but breadth can become style drift without rigorous position limits and transparent attribution. Investors should look for repeatable live returns, stable governance, low dilution, and increasing intrinsic value per share before assigning a strong moat.

How financially strong is SRX Global after the transformation?

At March 31, 2026, the company had $43.364 million of total assets, including $20.543 million of cash, $2.996 million of short-term investments, $8.333 million of digital assets, and $2.531 million of equity securities. It also carried $22.616 million of short-term convertible debt. The preliminary June 30 update then reported approximately $40 million of cash, more than $15 million of short-term investments, and no debt. The improvement is material, but the June figures remain unaudited until the next filing.

How is capital being allocated?

The board’s repurchase authorization is unusually large relative to the reported share count, so actual execution, average purchase price, and cash preservation are more important than the headline authorization.

Who owns and governs SRX Global?

Ownership changed sharply through financing transactions, the EMJX acquisition, and the 1-for-60 consolidation. The closing consideration included 268,346,659 common shares, 117,268,196 exchangeable shares convertible one-for-one into common stock, and pre-funded warrants for 44,368,530 common shares before the consolidation. The pre-closing information statement estimated that transaction transferors could hold about 43.85% of outstanding common shares under illustrative assumptions, but the actual closing mix and later consolidation mean that percentage should not be treated as a current beneficial-ownership table.

Which leaders shape execution?

The company’s executive-team page and board page provide current role descriptions. Governance analysis should focus on dilution controls, related-party review, portfolio valuation policy, custody, risk limits, and whether executive incentives reward per-share value rather than gross asset growth.

What opportunities and risks could change the story?

The opportunity set

The company has several ways to improve intrinsic value: expand Halo’s digital distribution, raise product margin, commercialize EMJX with institutional clients, earn low-risk interest on excess cash, acquire undervalued operating companies, and repurchase shares below conservatively measured NAV. Management’s multi-sector mandate can be valuable when markets are dislocated because the company is not tied to one industry.

The risk map

The company regained full NYSE American compliance on July 15, 2026, according to the latest listing-compliance Form 8-K. That resolves a near-term issue, but sustained compliance still depends on equity, price, reporting, and governance discipline.

Why is SRX Global difficult to value with a conventional DCF?

A single consolidated DCF is currently fragile because the company combines a small operating brand, liquid securities, digital assets, intellectual property, potential fee revenue, and future acquisitions. Historical revenue does not represent the post-June 2026 business, while portfolio gains are volatile and may not recur. A sum-of-the-parts approach is more informative: value Halo from normalized operating cash flow, mark liquid investments near realizable value with appropriate taxes and costs, value EMJX conservatively until live economics are demonstrated, then subtract corporate overhead and potential dilution.

Which KPIs belong in the model?

The most decision-useful dashboard includes Halo net sales, digital customer concentration, gross margin, SG&A, adjusted EBITDA, operating cash flow, portfolio fair value, realized return, maximum drawdown, cash and short-term investments, debt, fully diluted shares, and NAV per diluted share. The July 14 update reported a 24.8% paper-traded EMJX return over 149 days, but the company emphasized that no actual capital had been deployed. A valuation model should therefore treat that figure as evidence of a hypothesis, not as normalized earnings.

What is the key takeaway from SRX Global analysis?